Login
Registrati
Reimposta password
Pubblica & Distribuisci
Soluzioni Editoriali
Soluzioni di Distribuzione
Temi
Architettura e design
Arti
Business e Economia
Chimica
Chimica industriale
Farmacia
Filosofia
Fisica
Geoscienze
Ingegneria
Interesse generale
Legge
Letteratura
Linguistica e semiotica
Matematica
Medicina
Musica
Scienze bibliotecarie e dell'informazione, studi library
Scienze dei materiali
Scienze della vita
Scienze informatiche
Scienze sociali
Sport e tempo libero
Storia
Studi classici e del Vicino Oriente antico
Studi culturali
Studi ebraici
Teologia e religione
Pubblicazioni
Riviste
Libri
Atti
Editori
Blog
Contatti
Cerca
EUR
USD
GBP
Italiano
English
Deutsch
Polski
Español
Français
Italiano
Carrello
Home
Riviste
Acta Pharmaceutica
Volume 69 (2019): Numero 3 (September 2019)
Accesso libero
AKR1D1*36 C>T (rs1872930) allelic variant is associated with variability of the CYP2C9 genotype predicted pharmacokinetics of ibuprofen enantiomers – a pilot study in healthy volunteers
Aleksandra Kapedanovska Nestorovska
Aleksandra Kapedanovska Nestorovska
,
Krume Jakjovski
Krume Jakjovski
,
Zorica Naumovska
Zorica Naumovska
,
Zoran Sterjev
Zoran Sterjev
,
Nadica Matevska Geskovska
Nadica Matevska Geskovska
,
Kristina Mladenovska
Kristina Mladenovska
,
Ljubica Suturkova
Ljubica Suturkova
e
Aleksandar Dimovski
Aleksandar Dimovski
| 26 giu 2019
Acta Pharmaceutica
Volume 69 (2019): Numero 3 (September 2019)
INFORMAZIONI SU QUESTO ARTICOLO
Articolo precedente
Articolo Successivo
Sommario
Bibliografia
Autori
Articoli in questo Numero
Anteprima
PDF
Cita
CONDIVIDI
Pubblicato online:
26 giu 2019
Pagine:
399 - 412
Accettato:
18 feb 2019
DOI:
https://doi.org/10.2478/acph-2019-0032
Parole chiave
ibuprofen
,
enantiomers
,
pharmacokinetics
,
AKR1D1
,
CYP2C9
,
pharmacogenetics
© 2019 Aleksandra Kapedanovska Nestorovska et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Aleksandra Kapedanovska Nestorovska
Center for Biomolecular and Pharmaceutical Analysis, Faculty of Pharmacy, University Ss Cyril and Methodius
Skopje
Krume Jakjovski
Department of Preclinical and Clinical Pharmacology and Toxicology, Faculty of Medicine, University Ss Cyril and Methodius
Skopje
Zorica Naumovska
Center for Biomolecular and Pharmaceutical Analysis, Faculty of Pharmacy, University Ss Cyril and Methodius
Skopje
Zoran Sterjev
Center for Biomolecular and Pharmaceutical Analysis, Faculty of Pharmacy, University Ss Cyril and Methodius
Skopje
Nadica Matevska Geskovska
Center for Biomolecular and Pharmaceutical Analysis, Faculty of Pharmacy, University Ss Cyril and Methodius
Skopje
Kristina Mladenovska
Center for Biomolecular and Pharmaceutical Analysis, Faculty of Pharmacy, University Ss Cyril and Methodius
Skopje
Ljubica Suturkova
Center for Biomolecular and Pharmaceutical Analysis, Faculty of Pharmacy, University Ss Cyril and Methodius
Skopje
Aleksandar Dimovski
Center for Biomolecular and Pharmaceutical Analysis, Faculty of Pharmacy, University Ss Cyril and Methodius
Skopje
Research Center for Genetic Engineering and Biotechnology, “Georgi D. Efremov” Macedonian Academy of Sciences and Arts
Skopje